These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
296 related articles for article (PubMed ID: 27871833)
21. Dissolution-rate enhancement of fenofibrate by adsorption onto silica using supercritical carbon dioxide. Sanganwar GP; Gupta RB Int J Pharm; 2008 Aug; 360(1-2):213-8. PubMed ID: 18550302 [TBL] [Abstract][Full Text] [Related]
22. Enhanced dissolution and oral bioavailability of nifedipine by spontaneous emulsifying powders: effect of solid carriers and dietary state. Weerapol Y; Limmatvapirat S; Jansakul C; Takeuchi H; Sriamornsak P Eur J Pharm Biopharm; 2015 Apr; 91():25-34. PubMed ID: 25615879 [TBL] [Abstract][Full Text] [Related]
23. Improvement in oral bioavailability and dissolution of tanshinone IIA by preparation of solid dispersions with porous silica. Yan HM; Sun E; Cui L; Jia XB; Jin X J Pharm Pharmacol; 2015 Sep; 67(9):1207-14. PubMed ID: 25944009 [TBL] [Abstract][Full Text] [Related]
24. Stable and Fast-Dissolving Amorphous Drug Composites Preparation via Impregnation of Neusilin Azad M; Moreno J; Davé R J Pharm Sci; 2018 Jan; 107(1):170-182. PubMed ID: 29031953 [TBL] [Abstract][Full Text] [Related]
25. Molecular-level insight into hot-melt loading and drug release from mesoporous silica carriers. Lizoňová D; Mužík J; Šoltys M; Beránek J; Kazarian SG; Štěpánek F Eur J Pharm Biopharm; 2018 Sep; 130():327-335. PubMed ID: 30012403 [TBL] [Abstract][Full Text] [Related]
26. Dissolution and physicochemical stability enhancement of artemisinin and mefloquine co-formulation via nano-confinement with mesoporous SBA-15. Letchmanan K; Shen SC; Ng WK; Tan RBH Colloids Surf B Biointerfaces; 2017 Jul; 155():560-568. PubMed ID: 28499218 [TBL] [Abstract][Full Text] [Related]
27. Improvement of dissolution and absorption properties of poorly water-soluble drug by preparing spray-dried powders with alpha-glucosyl hesperidin. Uchiyama H; Tozuka Y; Imono M; Takeuchi H Int J Pharm; 2010 Jun; 392(1-2):101-6. PubMed ID: 20307634 [TBL] [Abstract][Full Text] [Related]
28. Ketoprofen mesoporous silica nanoparticles SBA-15 hard gelatin capsules: preparation and in vitro/in vivo characterization. Abd-Elrahman AA; El Nabarawi MA; Hassan DH; Taha AA Drug Deliv; 2016 Nov; 23(9):3387-3398. PubMed ID: 27167529 [TBL] [Abstract][Full Text] [Related]
29. Tadalafil inclusion in microporous silica as effective dissolution enhancer: optimization of loading procedure and molecular state characterization. Mehanna MM; Motawaa AM; Samaha MW J Pharm Sci; 2011 May; 100(5):1805-18. PubMed ID: 21374616 [TBL] [Abstract][Full Text] [Related]
30. Molecular structure and impact of amorphization strategies on intrinsic dissolution of spray dried indomethacin. Li Y; Rantanen J; Yang M; Bohr A Eur J Pharm Sci; 2019 Mar; 129():1-9. PubMed ID: 30553059 [TBL] [Abstract][Full Text] [Related]
31. Study on formulation variables of methotrexate loaded mesoporous MCM-41 nanoparticles for dissolution enhancement. Vadia N; Rajput S Eur J Pharm Sci; 2012 Jan; 45(1-2):8-18. PubMed ID: 22067974 [TBL] [Abstract][Full Text] [Related]
32. Characterization and evaluation of different mesoporous silica kinds as carriers for the development of effective oral dosage forms of glibenclamide. Mura P; Valleri M; Fabianelli E; Maestrelli F; Cirri M Int J Pharm; 2019 May; 563():43-52. PubMed ID: 30926527 [TBL] [Abstract][Full Text] [Related]
33. Mesoporous calcium carbonate as a phase stabilizer of amorphous celecoxib--an approach to increase the bioavailability of poorly soluble pharmaceutical substances. Forsgren J; Andersson M; Nilsson P; Mihranyan A Adv Healthc Mater; 2013 Nov; 2(11):1469-76. PubMed ID: 23703752 [TBL] [Abstract][Full Text] [Related]
34. Comparison of mesoporous silicon and non-ordered mesoporous silica materials as drug carriers for itraconazole. Kinnari P; Mäkilä E; Heikkilä T; Salonen J; Hirvonen J; Santos HA Int J Pharm; 2011 Jul; 414(1-2):148-56. PubMed ID: 21601623 [TBL] [Abstract][Full Text] [Related]
35. Enhancement of dissolution rate and oral absorption of a poorly water-soluble drug, K-832, by adsorption onto porous silica using supercritical carbon dioxide. Miura H; Kanebako M; Shirai H; Nakao H; Inagi T; Terada K Eur J Pharm Biopharm; 2010 Oct; 76(2):215-21. PubMed ID: 20603215 [TBL] [Abstract][Full Text] [Related]
36. Modified mesoporous silica nanoparticles for enhancing oral bioavailability and antihypertensive activity of poorly water soluble valsartan. Biswas N Eur J Pharm Sci; 2017 Mar; 99():152-160. PubMed ID: 27993684 [TBL] [Abstract][Full Text] [Related]
37. Development of novel core-shell dual-mesoporous silica nanoparticles for the production of high bioavailable controlled-release fenofibrate tablets. Zhao Z; Gao Y; Wu C; Hao Y; Zhao Y; Xu J Drug Dev Ind Pharm; 2016; 42(2):199-208. PubMed ID: 26114553 [TBL] [Abstract][Full Text] [Related]
38. Drug loading to mesoporous silica carriers by solvent evaporation: A comparative study of amorphization capacity and release kinetics. Šoltys M; Zůza D; Boleslavská T; Machač Akhlasová S; Balouch M; Kovačík P; Beránek J; Škalko-Basnet N; Flaten GE; Štěpánek F Int J Pharm; 2021 Sep; 607():120982. PubMed ID: 34371148 [TBL] [Abstract][Full Text] [Related]
39. Interplay of Adsorption, Supersaturation and the Presence of an Absorptive Sink on Drug Release from Mesoporous Silica-Based Formulations. Hate SS; Reutzel-Edens SM; Taylor LS Pharm Res; 2020 Aug; 37(8):163. PubMed ID: 32754797 [TBL] [Abstract][Full Text] [Related]
40. Electrosprayed mesoporous particles for improved aqueous solubility of a poorly water soluble anticancer agent: in vitro and ex vivo evaluation. Sayed E; Karavasili C; Ruparelia K; Haj-Ahmad R; Charalambopoulou G; Steriotis T; Giasafaki D; Cox P; Singh N; Giassafaki LN; Mpenekou A; Markopoulou CK; Vizirianakis IS; Chang MW; Fatouros DG; Ahmad Z J Control Release; 2018 May; 278():142-155. PubMed ID: 29605567 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]